T. Bauer (Berlin, Germany), P. Sliwinski (Warsaw, Poland)
Association of acinetobacter baumannii respiratory isolates with hospital outcomes in ventilated patients
L. C. Loh, C. T. J. YII, K. K. Lai, S. P. Seevaunnamtum, G. Pushparasah, J. M. G. Tong (Kuala Lumpur, Negeri Sembilan, Malaysia)
|  |
Study on the molecular epidemiology of stenotrophomonas maltophilia infection in patients on mechanical ventilation
S. L. Guo, Y. Xia, Y. A. Luo (Chongqing, China)
| |
Adrenal insufficiency and relative eosinophilia in critically ill patients with septic shock due to ventilator-associated pneumonia (VAP)
K. Katsaoulas, E. Mouloudi, M. Asimaki, C. Papageorgiou, N. Sounidakis, P. Pappas, A. Efthimiou, N. Gritsi-Gerogianni (Thessaloniki, Greece)
| |
Lung physiology and inflammatory markers in treated and untreated ventilator associated pneumonia (VAP), lessons learned from a porcine model
C. M. Luna, S. Baquero, S. Gando, J. Rizzo Patron, J. Garcia Morato, D. H. Goffredo, R. Absi, A. Famiglietti, C. A. Vay, G. Pargament, F. Von Stecher, O. Sibila, C. Agusti, A. Torres (Buenos Aires, Argentina; Barcelona, Spain)
| |
Ventilator-associated pneumonia: risk factors for antimicrobial-resistant causative pathogens
M. H. Ruiz, J. A. Guerrero, C. M. Romero (Santiago, Chile)
| |
Acinetobacter baumanii as a severity marker in a respiratory ICU
G. Brum, R. Macedo, J. Vizcaino, P. Azevedo, J. Monteiro, F. Monteiro, R. Soto-Mayor, A. Bugalho de Almeida (Lisbon, Portugal)
| |
Aerosolized colistin in critically ill patients for the treatment of ventilator-associated pneumonia, due to multidrug-resistant gram-negative bacteria
E. Mouloudi, K. Katsanoulas, M. Tsivitanidou, P. Pappas, A. Efthimiou, M. Asimaki, N. Sounidakis, N. Gritsi-Gerogianni (Thessaloniki, Greece)
| |
Specific treatment failure of the ventilator-associated pneumonia (VAP): predictive values
E. Chacón, A. Tejada, J. Casalduero, F. Clau, T. Martín, F. de Pablo, S. Bello (Zaragoza, Spain)
| |
Etiological features of late nosocomial pneumonia (NP) in patients of general surgical departments who had a prior antibacterial therapy (PAT)
T. O. Pertseva, R. O. Bontsevych, T. V. Kireeva (Dnipropetrovsk, Ukraine)
| |
BAL and microbiological surveillance of nosocomial pneumonia in ARDS patients
P. Martucci, D. Aronne, R. Giacobbe, L. B. Montella, M. R. Natale, B. del Prato (Naples, Italy)
| |
Differences in clinical courses of nosocomial pneumonia between patients of surgical and therapeutic departments
T. O. Pertseva, R. O. Bontsevych (Dnipropetrovsk, Ukraine)
| |
Carried MRSA in the active city hospital
M. Kato, N. Tanabe, S. Goto, K. Miura, M. Kawashima (Kishiwada, Japan)
| |
Antibiotic resistance among patients with lower respiratory tract infections who have undergone empiric treatment
P. T. Nikolova, Y. Y. Ivanov, E. D. Borisova, T. N. Simeonova, P. S. Pavlov (Pleven, Bulgaria)
| |
Antibiotics resistance of the gram-negative pathogens of bacterial respiratory infections (RI) in Belarus
V. A. Gorbunov, E. N. Nikolenko, L. K. Surkova, O. M. Zalutskaja (Minsk, Belarus)
| |
Impact of antibiotic consumption in the evolution of respiratory pseudomonas antibiotic resistance
J. Tárrega, C. Marti, M. Sagales, E. Barbeta (Granollers, Spain)
| |
Clinical efficacy and safety of micafungin in patients with pulmonary aspergillosis
K. Yoshimura, Y. Miyazaki, Y. Niki, R. Amitani, K. Ogawa, A. Kurashima, S. Kohno (Tokyo, Nagasaki, Okayama, Osaka, Nagoya, Japan)
| |
Assessment of the epidemiology and antibiotic resistance of the respiratory pathogens in the region of North-Eastern Bulgaria
K. Y. Yankov, K. N. Bojkova (Varna, Bulgaria)
| |
Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA
O. V. Plekhanova (Dniepropetrovsk, Ukraine)
| |